Volver

Bruker Corporation

Ticker: BRKR ISIN: US1167941087
Añadir al portafolio Análisis de cartera en 2min
Stock Mid-cap Dividend payer Trading above 200-day average
Capitalización
8,00 MM $
Forward P/E
23,75
Profit margin
-0,61%
Revenue growth QoQ
-0,50%
Div. yield
0,39%
Beta
1,17
56,98 $ -4,33%
Precio a fecha de 2026-08-24 · NASDAQ

Rendimiento por período

Rendimientos acumulados
1 Month -5,11%
6 Months +43,62%
1 Year +65,45%
5 Years -7,93% p.a.-33,83%
10 Years +10,13% p.a.+162,18%
Since inception +5,27% p.a.+260,50%
Rendimientos por año
YTD +21,24%
2025 -19,23%
2024 -19,99%
2023 +7,82%
2022 -18,29%
2021 +55,35%

Key stats

Market cap
8,00 MM
Dividend yield
0,39%
Beta
1,17
52-week range
28.46 - 64.32
50-day MA
44,41
200-day MA
39,13
Section 1

Business overview

Company profile data from fundamentals.

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. It offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper platform for bacterial and fungal identification and establish, DNA test strips, and; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions. It provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. The company was founded in 1960 and is headquartered in Billerica, Massachusetts.

Sector Healthcare
Industry Medical Devices
Country United States
Exchange NASDAQ
Section 2

Financial quality

Profitability and balance-sheet quality indicators from reported fundamentals.

Profitability

ROE -1,09%
ROA 3,68%
Profit margin -0,61%
Operating margin 12,96%
PEG ratio 3,64
Revenue/share TTM 22,67
Revenue TTM 3,44 MM
EBITDA 585,00 M
Gross profit TTM 1,68 MM
Beta 1,17

Valuation

Trailing P/E 0,00
Forward P/E 23,75
P/B 3,29
P/S 2,33
EV/EBITDA 33,55
EV/Revenue 2,83
Section 3

Earnings

Earnings metrics from company highlights and earnings datasets.

EPS estimate (current year) 1,88
Quarterly earnings growth 0,00%
Revenue TTM 3,44 MM
Reported quarters 102
Section 4

Dividends & corporate actions

Dividend and split fields from fundamentals.

Dividend yield 0,39%
Forward annual div. yield 0,38%
Dividend per share 0,2000
Payout ratio 11,56%
Ex-dividend date 2025-12-08
Last split date 0000-00-00
Section 5

Ownership / analyst view

Institutional ownership and analyst estimate fields when available.

Analyst

Analyst target price 52,36 $
Analyst rating 3.8571

Ownership & short interest

Shares outstanding 151,94 M
Shares float 103,31 M
Institutional ownership 90,20%
Insider ownership 31,94%
Short ratio 4,88
Short % of float 16,29%

Details

Instrument metadata and source update timestamps.

Symbol BRKR
Name Bruker Corporation
Asset type STOCK
Exchange NASDAQ
Currency USD
ISIN US1167941087
Country USA
Code + exchange BRKR.NASDAQ
Last price date 2026-01-06
Fundamentals updated 2026-01-07

La información proporcionada en esta plataforma es solo para fines informativos y no debe considerarse como asesoramiento financiero o de inversión. Insightfolio no ofrece asesoramiento financiero, recomendaciones personalizadas ni orientación sobre la compra, tenencia o venta de activos financieros. Las herramientas y contenidos son únicamente educativos y no están adaptados a las circunstancias, necesidades financieras u objetivos personales.

Insightfolio no asume ninguna responsabilidad por la precisión, integridad o fiabilidad de la información presentada. Es responsabilidad exclusiva de los usuarios verificar la información y tomar decisiones independientes basándose en su propia investigación y consideración. El uso de esta plataforma no reemplaza la consulta con profesionales financieros cualificados.

Invertir implica riesgos. Los usuarios deben ser conscientes de que el valor de las inversiones puede fluctuar y que los rendimientos pasados no son garantía de resultados futuros. Las decisiones de inversión deben basarse en objetivos financieros personales, tolerancia al riesgo y una evaluación independiente de la información relevante.

Insightfolio no respalda ni garantiza la idoneidad de ningún producto financiero, valor o estrategia en particular. Cualquier proyección, pronóstico o escenario hipotético presentado en la plataforma es solo ilustrativo y no constituye una garantía.

Al acceder a los servicios, información o contenido ofrecido por Insightfolio, los usuarios reconocen y aceptan los términos de este aviso legal. Si no estás de acuerdo con estos términos, por favor no uses nuestra plataforma.

Logotipos de instrumentos proporcionados por Elbstream.